Leonard S. Schleifer
Also at Regeneron Pharmaceuticals Inc
About
Leonard S. Schleifer has built a distinguished career in the biopharmaceutical industry by uniquely blending his expertise in medicine and research with innovative business leadership. His background in neurology and pharmacology has provided him with a solid foundation to drive complex research and strategic initiatives, positioning him as a key figure in groundbreaking drug development.
After founding REGN in 1988, he played an instrumental role in transforming the company into a leader in the field, overseeing the development of numerous innovative therapies and pioneering technologies. His leadership journey includes significant board-level responsibilities that have further underscored his commitment to excellence and continuous innovation in the biotechnology sector.
In addition to his professional achievements, his deep understanding of both the scientific and business aspects of the industry has been widely recognized, contributing to his reputation as an influential and visionary leader. His work continues to drive the company's success in an increasingly competitive market, reflecting his enduring impact on the biopharmaceutical landscape.
$REGN Performance Under Leonard S. Schleifer
Past Roles
Fixed Compensation
Performance Compensation
Cash-Based Performance Incentive
Calculation Detail:
Base Salary × Cash Incentive Target × Corporate Performance Multiplier = Total Cash Incentive Payout. For example, $1,875,415 × 1.20 × 1.9 = $4,275,946.
Additional Information:
- No individual performance multiplier was applied.
- The 2023 annual cash incentive pool was adjusted based on the company’s performance against predefined R&D-related goals.